Advertisement
Short communication| Volume 18, ISSUE 4, P541-542, December 1997

Successful prevention of posttransfusion hepatitis B by the combined use of immunoglobulin, vaccine and interferon

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kojima M
        • Shimizu M
        • Tsuchimochi T
        • et al.
        Posttransfusion fulminant hepatitis B associated with precore-defective mutants.
        Vox Sang. 1991; 60: 34-39
        • Itani Y
        • Ito K
        • Hori K
        • Tamori N
        A case of uterine endometrial cancer complicated post transfusion fatal fulminant hepatitis caused by hepatitis B virus with DNA mutation in precore region.
        Acta Obst Gynecol Jpn. 1995; 47: 1075-1078
        • Okamoto H
        • Yotsumoto S
        • Akahane Y
        • et al.
        Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.
        J Virol. 1990; 64: 1298-1303
        • Omata M
        • Ehata T
        • Yokosuka O
        • Hosoda K
        • Ohto M
        Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.
        N Engl J Med. 1991; 324: 1699-1704
        • Fagan EA
        • Smith PM
        • Davison F
        • Williams P
        Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males.
        Lancet. 1986; 328: 538-540